Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Faces of Innovation: Dr. Christine Petersen, researcher at University of Iowa

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Christine Petersen, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference, who researches how infectious diseases transmit between animals and people at the University of Iowa.

Recent

Research Roundup: Mosquitos and mice in the fight against Zika

Is it feasible or wise to eradicate mosquitoes? Could genetically-modified mosquitoes help researcher tackle the Zika virus? Learn more in this week's Research Roundup.

GHTC
Read More
Research Roundup: Identifying people at-risk for TB, a device to aid IUD insertion, and vaccines against cancer

In this week's Research Roundup, we look at gene risk for tuberculosis, a new tool to help with inserting IUDs, and vaccines to prevent and treat cancer.

GHTC
Read More
Take 1.5 minutes for 1.5 million lives

In this guest post, Dara Erck, vice president of External Affairs at Aeras, a global nonprofit biotechnology organization, highlights a new video launched on World TB Day to raise awareness of the urgent need for new tools to combat tuberculosis (TB).

Aeras
Read More
Research Roundup: cash prizes for R&D, genetically modified mosquitoes, and drones for rapid diagnosis

US Senator Bernie Sanders (I-VT) released a plan last week as part of his Democratic presidential bid to incentivize research and development (R&D) for new HIV/AIDS medicines while ensuring they remain affordable.

GHTC
Read More
Research Roundup: antibiotic resistance in preemies, a low-cost TB test, and more

A new study out of the Washington University School of Medicine in St. Louis, Missouri, revealed a proliferation of antibiotic-resistant bacteria in the gastrointestinal tracts of premature infants.

GHTC
Read More
Innovative health tools put the power of protection in women’s hands

This International Women’s Day, GHTC is celebrating two novel, female-initiated health technologies that have the potential to give women and girls greater control over their sexual and reproductive health, empowering them to make informed decisions about whether and when to have children and to protect themselves and their families from HIV and other sexually transmitted infections (STIs).

GHTC
Read More
Better together? Five takeaways on the proposal for a WHO pooled fund

Last week, GHTC convened a panel of experts to dissect and discuss a proposal for pooled funding for global health research and development (R&D).

Read More
Research Roundup: A novel single-pill HIV treatment, a promising Ebola therapy, and a collaboration between Google and UNICEF to map Zika

Gilead Sciences, a California-based biopharmaceutical company, has received US Food and Drug Administration (FDA) approval for Odefsey®, a complete, single-pill regimen for HIV/AIDS.

GHTC
Read More
Research Roundup: A vaginal ring to prevent HIV, antibodies against Ebola, and the US response to malaria

GHTC member the International Partnership for Microbicides (IPM) announced last week the results of two phase 3 clinical trials demonstrating that a monthly vaginal ring filled with the antiretroviral drug dapivirine can reduce the risk of HIV infection in women.

GHTC
Read More
Research Roundup: Vaccines for Rift Valley Fever, MERS, and Zika

A vaccine candidate against Rift Valley Fever appears to be safe and effective for livestock and has the potential for use in humans.

GHTC
Read More